Validation of the Korean version of inflammatory Rasch‐built Overall Disability Scale in patients with inflammatory neuropathy

Woohee Ju,Young Gi Min,Jong Su Kim,Jiwon Choi,Jiwon Lee,Seok‐Jin Choi,Sung‐Min Kim,Yoon‐Ho Hong,Jung‐Joon Sung
DOI: https://doi.org/10.1111/jns.12676
IF: 5.188
2024-12-12
Journal of the Peripheral Nervous System
Abstract:Background and Aims The Inflammatory Rasch‐built Overall Disability Scale (I‐RODS) is an effective activity measure for use in inflammatory peripheral neuropathy. The aim of this study was to validate the Korean version of the I‐RODS in patients with chronic inflammatory demyelinating polyneuropathy (CIDP), Guillain‐Barré syndrome (GBS), anti‐myelin‐associated glycoprotein (MAG) neuropathy, and autoimmune nodopathy. Methods A total of 120 patients underwent clinical evaluations, which included the I‐RODS, Inflammatory Neuropathy Cause and Treatment (INCAT) assessment, and Jamar grip strength (kg) measurement. Follow‐up assessments were performed for 83 patients during their regular clinic visits. To estimate the test–retest reliability of the I‐RODS, the scale was reapplied to a subset of 16 patients within 2–7 days of the initial test. Overall, reliability, validity, and responsiveness of the I‐RODS were evaluated. Results Internal consistency was good, as indicated by a person separation index of 0.966. The raw and standardized Cronbach's alpha values were both 0.974. The test–retest reliability analyzed using the intraclass correlation coefficient (ICC) was also high (ICC = 0.972). The I‐RODS showed a strong correlation with INCAT scores (ρ = −0.81, p
neurosciences,clinical neurology
What problem does this paper attempt to address?